hygeia health (06078.HK) spent 0.856 million Hong Kong dollars to repurchase 0.055 million shares on December 5th.

Gelonghui reported on December 5 that hygeia health (06078.HK) announced that on December 5, it spent 0.856 million HKD to repurchase 0.055 million shares.

Gelonghui FinanceDec 5 04:48 ET

One Hygeia Healthcare Holdings Insider Raised Their Stake In The Previous Year

Simply Wall StDec 4 17:25 ET

hygeia health (06078.HK) spent 1.7487 million Hong Kong dollars on repurchasing 0.1122 million shares on December 4th.

Galaxy glory December 4th | Hygeia Health (06078.HK) announced that on December 4th, it spent 1.7487 million Hong Kong dollars to repurchase 0.1122 million shares, with a repurchase price per share of 15.52-15.64 Hong Kong dollars.

Gelonghui FinanceDec 4 04:35 ET

hygeia health (06078.HK) spent 1.197 million Hong Kong dollars on repurchasing 0.076 million shares on November 28th.

The Hygeia Health (06078.HK) announced on November 28 that it will spend 1.197 million Hong Kong dollars to buy back 0.076 million shares on November 28, 2024, at a repurchase price of 15.72-15.78 Hong Kong dollars per share.

Gelonghui FinanceNov 28 04:38 ET

[Brokerage Focus] Bocom Intl: Inflection point of the pharmaceutical sector has arrived in 2025, focusing on innovation and fundamental recovery.

Kingwo Financial News | bocom intl states that the turning point for the pharmaceutical global sectors has arrived, with two main lines to focus on in 2025: the pharmaceutical sector ended years of underperformance against the large cap in the second half of 2024, and the bank is bullish on the opportunity for this trend to continue in 2025. The bank believes that: 1) In the short term, the recovery of the macro environment and the interest rate cut cycle are expected to drive the overall sector rebound's beta opportunities; 2) Alpha opportunities can be summarized into two main lines: a) outstanding innovative capability while considering the potential for product exports; b) the bearish sentiment has run its course, leading to valuation bottoms and performance reversal, which is the Davis double hit opportunity. The bank points out that 1) innovative drugs going abroad to trade and

Golden Guard Financial NewsNov 27 20:00 ET

hygeia health (06078.HK) spent 1.603 million Hong Kong dollars to repurchase 0.101 million shares on November 27.

Gelonghui reported on November 27 that hygeia health (06078.HK) announced that on November 27, it spent 1.603 million Hong Kong dollars to buy back 0.101 million shares.

Gelonghui FinanceNov 27 05:21 ET